Stock-Based Compensation (Details) (USD $) | 3 Months Ended | 6 Months Ended | 9 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | 3 Months Ended | 9 Months Ended | | | | 9 Months Ended | |
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Jun. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Mar. 31, 2014 | Sep. 30, 2013 | Jun. 30, 2014 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Mar. 31, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2014 | 31-May-14 | Apr. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 |
| Stock Options | Stock Options | Stock Options | Stock Options | Stock Options | Stock Options | Restricted Shares | Restricted Shares | Restricted Shares | Restricted Shares | Restricted Shares | 2000 Employee Option Plan | 2009 Employee Option Plan | 2009 Employee Option Plan | 2009 Employee Option Plan | 2000 Employee Option Plan and 2009 Employee Option Plan | 2004 Directors Option Plan | 2012 Directors Restricted Stock Plan |
Share-based Compensation Arrangement by Share-based Payment Award | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of additional stock options that can be granted (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' | ' | ' |
Common Stock reserved for issuance | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 58,000,000 | 32,000,000 | ' | ' | ' |
Shares available for the granting of additional stock options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 24,788,660 | ' | ' | ' | 140,000 | 171,922 |
Options ratable vesting period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | '3 years | ' |
Options exercisable period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | '10 years | ' |
Number of additional stock options expected to be granted (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' |
Expense incurred for stock-based compensation plans (in dollars) | $10,133 | $9,413 | ' | $29,382 | $19,432 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expense incurred for stock-based compensation plans, net of tax (in dollars) | 7,512 | 6,940 | ' | 21,649 | -26,584 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock option activity | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options outstanding at the beginning of the period (in shares) | ' | ' | ' | ' | ' | 29,866,530 | 26,844,452 | ' | 26,844,452 | 26,844,452 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options granted (in shares) | ' | ' | ' | ' | ' | ' | 65,000 | ' | 6,047,000 | 108,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options exercised (in shares) | ' | ' | ' | ' | ' | ' | -629,932 | ' | -2,257,950 | -1,483,440 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options forfeited (in shares) | ' | ' | ' | ' | ' | ' | -102,920 | ' | -99,120 | -94,320 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options outstanding at the end of the period (in shares) | ' | ' | ' | ' | ' | 28,396,770 | 26,176,600 | ' | 29,866,530 | 28,396,770 | 26,844,452 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested and non-vested options expected to vest at the end of the period (in shares) | ' | ' | ' | ' | ' | 25,649,402 | ' | ' | ' | 25,649,402 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Exercisable at the end of the period (in shares) | ' | ' | ' | ' | ' | 11,775,650 | ' | ' | ' | 11,775,650 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share) | ' | ' | ' | ' | ' | $30.90 | $25.90 | ' | $25.90 | $25.90 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options granted (in dollars per share) | ' | ' | ' | ' | ' | ' | $44.57 | ' | $47.72 | $48.77 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options exercised (in dollars per share) | ' | ' | ' | ' | ' | ' | $20.21 | ' | $19.90 | $20.47 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options forfeited (in dollars per share) | ' | ' | ' | ' | ' | ' | $29.90 | ' | $32.61 | $36.39 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options outstanding at the end of the period (in dollars per share) | ' | ' | ' | ' | ' | $31.49 | $26.07 | ' | $30.90 | $31.49 | $25.90 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, vested and non-vested options expected to vest (in dollars per share) | ' | ' | ' | ' | ' | $31.10 | ' | ' | ' | $31.10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, exercisable (in dollars per share) | ' | ' | ' | ' | ' | $23.11 | ' | ' | ' | $23.11 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Remaining Contractual Term | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term of options outstanding | ' | ' | '7 years 5 months 16 days | '7 years 3 months 26 days | ' | ' | '6 years 10 months 21 days | ' | ' | ' | '7 years 29 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term of options vested options and non-vested expected to vest | ' | ' | ' | ' | ' | ' | ' | ' | ' | '7 years 2 months 23 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term of options exercisable | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years 8 months 27 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate Intrinsic Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value of options outstanding (in dollars) | ' | ' | ' | ' | ' | 523,618 | 517,164 | ' | 515,908 | 523,618 | 501,706 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value of options, vested and non-vested options expected to vest (in dollars) | ' | ' | ' | ' | ' | 483,163 | ' | ' | ' | 483,163 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value of options exercisable (in dollars) | ' | ' | ' | ' | ' | 315,886 | ' | ' | ' | 315,886 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Status of the Company's non-vested options and changes during the year | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options at the beginning of the period (in shares) | ' | ' | ' | ' | ' | 16,633,780 | 16,033,842 | ' | 16,033,842 | 16,033,842 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options, options granted (in shares) | ' | ' | ' | ' | ' | ' | 65,000 | ' | 6,047,000 | 108,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options, options vested (in shares) | ' | ' | ' | ' | ' | ' | -14,000 | ' | -5,296,022 | -26,340 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options, options forfeited (in shares) | ' | ' | ' | ' | ' | ' | -102,920 | ' | -99,120 | -94,320 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options at the end of the period (in shares) | ' | ' | ' | ' | ' | 16,621,120 | 15,981,922 | ' | 16,633,780 | 16,621,120 | 16,033,842 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Fair Value at Grant Date | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share) | ' | ' | ' | ' | ' | $7.97 | $7.39 | ' | $7.39 | $7.39 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at grant date, options granted (in dollars per share) | ' | ' | ' | ' | ' | ' | $10.62 | ' | $8.62 | $8.85 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at grant date, options vested (in dollars per share) | ' | ' | ' | ' | ' | ' | $8.49 | ' | $6.98 | $8.33 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at grant date, options forfeited (in dollars per share) | ' | ' | ' | ' | ' | ' | $7.41 | ' | $7.66 | $8 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share) | ' | ' | ' | ' | ' | $7.98 | $7.40 | ' | $7.97 | $7.98 | $7.39 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total intrinsic value of stock options exercised (in dollars) | ' | ' | ' | 123,911 | 91,091 | 45,458 | ' | 16,456 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total fair value of stock options vested (in dollars) | ' | ' | ' | 37,277 | 33,830 | 219 | ' | 49 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total compensation cost related to non-vested options not yet recognized (in dollars) | ' | ' | ' | ' | ' | 104,618 | 104,618 | ' | ' | 104,618 | ' | 562 | ' | ' | 562 | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average expected amortization period | ' | ' | ' | ' | ' | ' | '3 years 7 months 2 days | ' | ' | '3 years 7 months 2 days | ' | ' | '7 months 24 days | ' | '7 months 6 days | ' | ' | ' | ' | ' | ' | ' | ' |
Number of restricted shares issued | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 18,340 | ' | 25,648 | ' | 34,090 | ' | ' | ' | ' | ' | ' | ' |
Weighted-average grant date fair value of restricted shares (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $47.72 | ' | $39 | ' | $26.89 | ' | ' | ' | ' | ' | ' | ' |
Total compensation cost related to non-vested restricted shares not yet recognized (in dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $562 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |